Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$105M Sell
1,098,136
-110,171
-9% -$9.96M 0.08% 255
2014
Q2
$110M Sell
1,208,307
-1,849,025
-60% -$166M 0.09% 239
2014
Q1
$269M Buy
3,057,332
+75,984
+3% +$6.67M 0.24% 82
2013
Q4
$277M Buy
2,981,348
+150,667
+5% +$13.6M 0.26% 75
2013
Q3
$231M Buy
2,830,681
+175,516
+7% +$14.8M 0.24% 80
2013
Q2
$221M Buy
+2,655,165
New +$228M 0.26% 68

Other funds holding CLX

UBS's CLX Position: Q3 2014 in Review

UBS reduced its Clorox (CLX) stake by 9.1% in Q3 2014, selling an estimated $9.96M and leaving 1,098,136 shares worth $105M. The position accounts for 0.08% of the portfolio, ranked #255.

UBS first reported a position in CLX in Q2 2013 and has held it in 6 quarters since. The position peaked at $277M in Q4 2013. 676 funds tracked by Wall St. Rank hold CLX as of Q3 2014.

  • UBS held 1,098,136 shares of Clorox worth $105M as of Q3 2014.
  • UBS sold 110,171 Clorox shares in Q3 2014, an estimated $9.96M.
  • Clorox made up 0.08% of UBS's portfolio in Q3 2014, its #255 holding.
  • UBS first reported a position in Clorox in Q2 2013 and has held it in 6 quarters since.
  • UBS's Clorox position peaked at $277M in Q4 2013.
  • 676 funds tracked by Wall St. Rank held Clorox as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.